C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils.

Activated sphingomyelinases release ceramide molecules believed to be involved in intracellular signalling. The present study investigated whether soluble C2-ceramide modulates some of the effects of N-formylmethionylleucyl phenylalanine (fMLP) and other agonists on human neutrophils (or polymorphonuclear leukocytes-PMN); principally superoxide anion (O2-) production. The preincubation of PMN for 15 min with C2-ceramide increased by up to almost 3-fold the amounts of O2- generated in response to 0.1 and 1 microM fMLP. Priming was detected at C2-ceramide concentrations of 2 microM to 4 microM per million PMN. Though less potent than C2-ceramide, C6-ceramide (N-hexanoylsphingosine) could prime for O2- generated in response to 0.1 microM fMLP, with maximal effects obtained at 10-20 microM. In contrast, micromolar concentrations of sphingosine, dihydroceramide, and ceramide-phosphate, failed to exert any potentiating effect on fMLP-induced O2- generation. As expected, TNF-alpha (1000 U/ml), also primed for fMLP-induced O2- production; however, the combination of TNF-alpha and C2-ceramide showed no additive effect. Moreover, S. aureus sphingomyelinase (0.1 U/ml), was unable to reproduce the priming effects of C2-ceramide and TNF-alpha. C2-ceramide at 2 microM did not enhance the production of O2- induced by 100 nM recombinant human interleukin-8 (IL-8), leukotriene B4 (LTB4), platelet-activating factor (PAF) or 20 mM sodium fluoride (NaF). Furthermore, C2-ceramide (2 microM) did not enhance the mobilization of calcium, the release of arachidonic acid or the accumulation of phosphatidylethanol, induced by 100 nM fMLP. This suggests that probably neither phospholipases C, A2 or D (PLC, PLA2, PLD) were involved in the priming effect by C2-ceramide. However, C2-ceramide inhibited in a dose-related manner the production of O2- induced by phorbol 12-myristate 13-acetate (PMA) and mezerein. Furthermore, PMA-stimulated PLD activity was also significantly reduced by a preincubation of PMN with C2-ceramide. The priming of O2- production by C2-ceramide could involve yet unidentified mechanisms specific for fMLP, or it might imply that cytokines such as TNF-alpha have different mechanisms than C2-ceramide.

Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity.

Interleukin-8 (IL-8) and the structurally related cytokines neutrophil-activating peptide-2 (NAP-2) and GRO alpha are powerful chemotactic agents for human neutrophils. Although these three chemokines act by binding to overlapping but not identical receptor subsets, the data available to date have stressed the similarities in their mechanisms of action. The present studies were undertaken to further our understanding of the signal transduction mechanisms associated with these neutrophil agonists. IL-8, NAP-2, and GRO alpha stimulated similar increases in the level of cytoplasmic free calcium. They were also shown to stimulate qualitatively similar increases in the levels of protein tyrosine phosphorylation. In contrast, only IL-8 enhanced the formation of phosphatidylethanol (PEt), the product catalyzed by phospholipase D (PLD) in the presence of ethanol. The formation of PEt stimulated by IL-8 was inhibited by pertussis toxin and the tyrosine kinase inhibitors erbstatin and herbimycin A. The ability of IL-8 to stimulate the activity of PLD was additively enhanced, or primed, by cytochalasin B and by tumor necrosis factor alpha. Although all three chemokines increased the level of free cytoplasmic calcium to the same extent, IL-8 was significantly more potent than either NAP-2 or GRO alpha with respect to its ability to enhance CD11b expression and to stimulate chemotactic and oxidative responses. The differences between IL-8, NAP-2, and GRO alpha in their ability to stimulate PLD is likely to be related to their respective binding affinities for the two IL-8 receptors (IL-8R-A and IL-8R-B). These results suggest that the signalling pathways activated by IL-8R-A and IL-8R-B diverge at a step preceding the activation of PLD.

Fluorescence characteristics of pyrene and phosphatidylethanolamine-bound pyrene incorporated into lipid vesicles solubilized in media of differing NaCl concentrations.

We used the excimer/monomer ratio of pyrene (PY) and N-(1-pyrenesulfonyl)dipalmitoyl-L-alpha-phosphatidylethanolamine (DPPE-PY) fluorescence intensities (IE/IM), and the polarity ratio I/III to investigate the state of the polar head group region of small, unilamellar phosphatidylcholine vesicles (SUV-PC) solubilized in media of differing NaCl concentrations. PY or DPPE-PY excimer formation resulting from vesicles' collisions is not affected by the presence of monovalent ions. In addition, the ionic strength does not alter the dielectric environment in the neighborhood of PY incorporated into SUV-PC. Since IE/IM of both PY and DPPE-PY is insensitive to variations in the ionic strength, we conclude that the probes' diffusion in SUV-PC, and consequently the membrane fluidity, are independent of NaCl concentration at least up to 0.5 M. The vesicles' concentration in the aqueous solution was the only factor which induced a rise of IE/IM. To explain the results in the context of the transient-fusion model developed previously (G.P. L'Heureux and M. Fragata, Biophys. Chem. 30 (1988) 293) and the hypothesis of repulsive hydration forces, we postulate a heterogeneous distribution of dehydrated domains, or contact areas, on the outer surfaces of colliding vesicles.

Micropolarities of lipid bilayers and micelles. 5. Localization of pyrene in small unilamellar phosphatidylcholine vesicles.

The excimer/monomer ratio of emission intensities (IE/IM) and the enhancement of the 0-0 vibronic transition in the fluorescence spectra of pyrene (PY) and 16-(1-pyrenyl)hexadecanoic acid (C16PY) were used to investigate the localization of PY in the bilayers of small unilamellar vesicles constituted of phosphatidylcholine (SUV-PC). First, from comparison of the fluorescence characteristics of PY in water with those of PY incorporated into the SUV-PC membranes, we concluded that the probe is incorporated preferentially in the lipid phase of the vesicles and not in the bulk aqueous phase. In addition, we found that, contrary to what happens with the pyrenyl moiety of C16PY, the location of PY varies with its relative concentration in the membrane space. The critical concentration was observed to be around 1.0 mol% of incorporated PY. At concentrations below this value, PY is located in the hydrocarbon core of the lipid bilayers. Above 1.0 mol%, the PY molecules reside preferentially in the neighbourhood of the glyceryl moiety region of the PC vesicles.